Question 1

What is Ocrelizumab used for?

Accepted Answer

Ocrelizumab (brand name Ocrevus) is a Anti-CD20 Monoclonal Antibody indicated for Relapsing Multiple Sclerosis, Primary Progressive MS.

Question 2

How does Ocrelizumab work?

Accepted Answer

Ocrelizumab works through the following mechanism: Humanized anti-CD20 monoclonal antibody that depletes B cells via antibody-dependent cellular cytolysis and complement-mediated lysis..

Question 3

What are the most common side effects of Ocrelizumab?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Ocrelizumab. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Ocrelizumab the same as Ocrevus?

Accepted Answer

Ocrevus is a brand name for Ocrelizumab. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Ocrelizumab

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations